person
Andrzej M.
- Country
- Poland
- Department
- Centrum Medyczne Mruk-Med
Research Overview
assignment
31
Clinical Trials ·
- Palazestrant and Ribociclib versus Letrozole and Ribociclib for First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC)
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
477
Sites with multiple studies
Has run more than one trial at 477 of 777 partner sites.
Specializations
Breast Cancer Specialization
This investigator demonstrates extensive involvement in research targeting various forms of breast cancer, with particular focus on HER2-positive, hormone receptor-positive, and triple-negative breast cancer subtypes.
- Advanced metastatic breast cancer treatment
- Early-stage breast cancer interventions
- HER2-targeted therapies
- Hormone receptor-positive disease management
Lung Cancer Research
The investigator conducts significant research in lung cancer treatment, focusing on both small cell lung cancer and non-small cell lung cancer therapeutic approaches.
- Advanced NSCLC treatments
- SCLC therapy development
- Novel therapeutic combinations
- Targeted molecular therapies
Gastrointestinal Oncology
Research extends to various gastrointestinal cancers, including colorectal cancer, hepatocellular carcinoma, and biliary tract cancers.
- Metastatic colorectal cancer treatments
- HER2-positive colorectal cancer
- Advanced hepatocellular carcinoma
- Gastroesophageal cancer therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.